{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:01:01Z","timestamp":1793628061579,"version":"4.5.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Aldehyde dehydrogenase 2 (ALDH2) is well-known to be a key enzyme in alcohol metabolism. However, a comprehensive understanding of ALDH2 across human cancers is lacking.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A systematic and comprehensive analysis of the molecular alterations and clinical relevance for ALDH2 in more than 10,000 samples from 33 cancer types was performed. qRT-PCR was performed on 60 cancer and 60 paired nontumor tissues.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> It was observed that ALDH2 was generally downregulated in most cancers, which was mainly driven by DNA hypermethylation rather than mutations or copy number variations. Besides, ALDH2 was closely related to the inhibition and activation of tumor pathways and a variety of potential targeted agents had been discovered in our research. Last but not least, ALDH2 had the best prediction efficacy in assessing immunotherapeutic response compared with PD-L1, PD-1, CTLA4, CD8, and tumor mutation burden (TMB) in cutaneous melanoma. According to the analysis of large-scale public data and 60 pairs of clinical cancer samples, we found the downregulation of ALDH2 expression tends to suggest the malignant phenotypes and adverse prognosis, which might enhance the precise diagnosis and timely intervention of cancer patients.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study advanced the understanding of ALDH2 across cancers, and provided important insight into chemotherapy, immunotherapy and prognosis of patients with cancer.<\/jats:p>","DOI":"10.3389\/fmed.2021.832605","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T05:31:42Z","timestamp":1642051902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Molecular Characterization and Clinical Relevance of ALDH2 in Human Cancers"],"prefix":"10.3389","volume":"8","author":[{"given":"Bo","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaoqu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-13-3292","article-title":"Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway","volume":"20","author":"Shao","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2013","article-title":"Targeting aldehyde dehydrogenase 2: new therapeutic opportunities","volume":"94","author":"Chen","year":"2014","journal-title":"Physiol Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-981-13-6260-6_13","article-title":"ALDH2 and cancer therapy","volume":"1193","author":"Wang","year":"2019","journal-title":"Adv Exp Med Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12929-017-0327-y","article-title":"ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective","volume":"24","author":"Chang","year":"2017","journal-title":"J Biomed Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s13402-018-0390-8","article-title":"Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients","volume":"41","author":"Chen","year":"2018","journal-title":"Cell Oncol (Dordr)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/bju.12641","article-title":"Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study","volume":"115","author":"Andrew","year":"2015","journal-title":"BJU Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/hep.29006","article-title":"Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice","volume":"65","author":"Hou","year":"2017","journal-title":"Hepatology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.freeradbiomed.2011.11.033","article-title":"Aldehyde dehydrogenases and cell proliferation","volume":"52","author":"Muzio","year":"2012","journal-title":"Free Radic Biol Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cbi.2011.10.007","article-title":"The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance","volume":"195","author":"Moreb","year":"2012","journal-title":"Chem Biol Interact."},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-017-0338-8","article-title":"Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment","volume":"24","author":"Kim","year":"2017","journal-title":"J Biomed Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.yexcr.2017.11.004","article-title":"Targeting ALDH2 with disulfiram\/copper reverses the resistance of cancer cells to microtubule inhibitors","volume":"362","author":"Wang","year":"2018","journal-title":"Exp Cell Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/bjc.2012.442","article-title":"Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells","volume":"107","author":"Liu","year":"2012","journal-title":"Br J Cancer."},{"key":"B13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ccell.2019.01.011","article-title":"Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer","volume":"35","author":"Hellmann","year":"2019","journal-title":"Cancer Cell."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/s41467-017-01460-0","article-title":"Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma","volume":"8","author":"Lauss","year":"2017","journal-title":"Nat Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell."},{"key":"B16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1101\/gr.221077.117","article-title":"Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies","volume":"27","author":"Geeleher","year":"2017","journal-title":"Genome Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2059-5","article-title":"Alcohol-derived DNA crosslinks are repaired by two distinct mechanisms","volume":"579","author":"Hodskinson","year":"2020","journal-title":"Nature."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.832605\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T05:31:44Z","timestamp":1642051904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.832605\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":19,"alternative-id":["10.3389\/fmed.2021.832605"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.832605","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"article-number":"832605"}}